Vivos Therapeutics
VVOS
VVOS
31 hedge funds and large institutions have $2.39M invested in Vivos Therapeutics in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 6 closing their positions.
Holders
31
Holders Change
+1
Holders Change %
+3.33%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
8
Closed
6
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
-$7K
Top Buyers
Top Sellers
| 1 |
BA
1
Bard Associates
Chicago,
Illinois
|
$0 |
| 2 |
2
Renaissance Technologies
New York
|
$17K |
| 3 |
3
BlackRock
New York
|
$1.19K |
| 4 |
4
Two Sigma Investments
New York
|
$32.3K |
| 5 |
5
Millennium Management
New York
|
$0 |
